Login
Toggle navigation
Videos
Categories
Trending
Punit Dhillon, President & CEO of OncoSec Medical
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
OncoSec Medical - Biotech Company Developing Treatments for Advanced-stage Skin Cancer
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Democratizing Private Markets for Retail Investors
00:10:00
Ryan Schneider Discusses Rebranding to Anywhere Real Estate and Current Housing Market Trends|CEO, Anywhere Real Estate Inc
00:10:00
Brett Robinson on CHIPS Act and U.S. Semiconductor Manufacturing
00:10:00
Key Updates on Concessions, Commodity Impacts, and U.S. Critical Minerals Strategy
00:10:00
Gain Insights from Elad Gil's Two Decades of Experience! Join EO Builders for Exclusive Access to Founders' Wisdom and Global Networking Opportunities| Elad Gil, Investor,EO
00:10:00
Platinum Group Metals (PGM) Market Outlook: Key Factors and Trends
00:10:00
Matthew Gill of White Rock Minerals Discusses Dual Projects in Australia and Alaska, Emphasizing Growth and Value at One-to-One Conference
00:10:00
Cohort plc Investor Presentation: Strong Results and Growth Outlook | Andrew Thomis - CEO of cohort plc
00:10:00
Value Investing in a Changing World: Adapting Strategies for Sustainable Success | Dato’ Seri Cheah Cheng Hye, Co-Chairman , Value Partners .
00:00:00
Innovation to Impact: Knee Outcomes for Medical Professionals-Daniel B. F. Saris, M.D., Ph.D. Orthopedic Surgeon, Mayo Clinic
00:10:00
American Creek Resources: Breakthrough Resource Estimate at Treaty Creek
00:10:00
"Lazard Asset Management hosts an insightful summit on family offices and asset management, facilitating strategic discussions and networking opportunities."|Evan L. Russo became Chief Executive Officer of Lazard's Asset Management